FI905663A0 - FOERFARANDE FOER ERHAOLLANDE AV PYRIDAZINDERIVAT, VILKA AER ANVAENDBARA SOM LIGNDER AV ACETYLKOLINAKTIGA RECEPTORER. - Google Patents

FOERFARANDE FOER ERHAOLLANDE AV PYRIDAZINDERIVAT, VILKA AER ANVAENDBARA SOM LIGNDER AV ACETYLKOLINAKTIGA RECEPTORER.

Info

Publication number
FI905663A0
FI905663A0 FI905663A FI905663A FI905663A0 FI 905663 A0 FI905663 A0 FI 905663A0 FI 905663 A FI905663 A FI 905663A FI 905663 A FI905663 A FI 905663A FI 905663 A0 FI905663 A0 FI 905663A0
Authority
FI
Finland
Prior art keywords
receptorer
pyridazinderivat
lignder
erhaollande
acetylkolinaktiga
Prior art date
Application number
FI905663A
Other languages
Finnish (fi)
Other versions
FI101881B1 (en
FI905663A (en
FI101881B (en
Inventor
Robert Boigegrain
Roger Brodin
Jean Paul Kan
Dominique Olliero
Camille Georges Wermuth
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR8915137A external-priority patent/FR2654727B1/en
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of FI905663A0 publication Critical patent/FI905663A0/en
Publication of FI905663A publication Critical patent/FI905663A/en
Priority to MX9203714A priority Critical patent/MX9203714A/en
Application granted granted Critical
Publication of FI101881B1 publication Critical patent/FI101881B1/en
Publication of FI101881B publication Critical patent/FI101881B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
FI905663A 1989-11-17 1990-11-15 A process for the preparation of 3-aminopyridazine derivatives useful as ligands for acetylcholine-like receptors FI101881B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MX9203714A MX9203714A (en) 1989-11-17 1992-06-29 DERIVATIVES OF PIRIDAZINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR8915137 1989-11-17
FR8915137A FR2654727B1 (en) 1989-11-17 1989-11-17 PYRIDAZINE DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
FR909007533A FR2663326B2 (en) 1989-11-17 1990-06-15 PYRIDAZINE DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
FR9007533 1990-06-15

Publications (4)

Publication Number Publication Date
FI905663A0 true FI905663A0 (en) 1990-11-15
FI905663A FI905663A (en) 1991-05-18
FI101881B1 FI101881B1 (en) 1998-09-15
FI101881B FI101881B (en) 1998-09-15

Family

ID=26227673

Family Applications (1)

Application Number Title Priority Date Filing Date
FI905663A FI101881B (en) 1989-11-17 1990-11-15 A process for the preparation of 3-aminopyridazine derivatives useful as ligands for acetylcholine-like receptors

Country Status (21)

Country Link
EP (1) EP0429344B1 (en)
JP (1) JPH03170465A (en)
KR (1) KR0164599B1 (en)
AR (1) AR247557A1 (en)
AT (1) ATE143010T1 (en)
AU (1) AU639043B2 (en)
CA (1) CA2030133A1 (en)
DE (1) DE69028602T2 (en)
DK (1) DK0429344T3 (en)
ES (1) ES2094146T3 (en)
FI (1) FI101881B (en)
FR (1) FR2663326B2 (en)
GR (1) GR3021933T3 (en)
HK (1) HK1000597A1 (en)
HU (2) HU207852B (en)
IE (1) IE75697B1 (en)
IL (1) IL96384A (en)
LV (1) LV11972B (en)
NO (1) NO178967C (en)
NZ (1) NZ236107A (en)
PT (1) PT95902B (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2665442B1 (en) * 1990-07-31 1992-12-04 Sanofi Sa ALKYL-6 PYRIDAZINE DERIVATIVES, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
FR2676444B1 (en) * 1991-05-16 1995-03-10 Sanofi Elf NOVEL AMINO-3 PYRIDAZINE DERIVATIVES ACTIVE IN THE CENTRAL NERVOUS SYSTEM, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME.
WO1997026258A1 (en) * 1996-01-15 1997-07-24 Janssen Pharmaceutica N.V. Angiogenesis inhibiting pyridazinamines
PT1042293E (en) * 1997-12-19 2008-04-18 Amgen Inc Substituted pyridine and pyridazine compounds and their pharmaceutical use
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
DE60227498D1 (en) 2001-03-23 2008-08-21 Advanced Bionutrition Corp DISTRIBUTION OF AGENTS FOR THE CONTROL OF AFFECTS IN AQUACULTURE USING BIOACTIVE PROTEINS CONTAINING YEAST
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
US7678363B2 (en) 2005-08-26 2010-03-16 Braincells Inc Methods of treating psychiatric conditions comprising administration of muscarinic agents in combination with SSRIs
KR20080081914A (en) * 2005-12-07 2008-09-10 스미또모 가가꾸 가부시끼가이샤 Pyridazine compound and use thereof
FR2904314A1 (en) * 2006-07-26 2008-02-01 Centre Nat Rech Scient LINEAR PYRIDAZINIC AND PYRROLIC COMPOUNDS, METHODS OF OBTAINING AND APPLICATIONS
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (en) 2010-04-23 2012-08-08 Cytokinetics Inc AMINO- PYRIMIDINES COMPOSITIONS OF THE SAME AND METHODS FOR THE USE OF THE SAME
AR081626A1 (en) * 2010-04-23 2012-10-10 Cytokinetics Inc AMINO-PYRIDAZINIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND USE OF THE SAME TO TREAT CARDIAC AND SKELETIC MUSCULAR DISORDERS
AR119731A1 (en) 2019-05-17 2022-01-05 Novartis Ag NLRP3 INFLAMASOME INHIBITORS
JP2024505735A (en) * 2021-02-08 2024-02-07 メッドシャイン ディスカバリー インコーポレイテッド Substituted pyridazine phenolic derivatives

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510998B1 (en) * 1981-08-07 1986-01-10 Sanofi Sa NOVEL AMINO DERIVATIVES OF PYRIDAZINE, PROCESS FOR THEIR PREPARATION AND DRINKING ACTS THEREOF
FR2540113A1 (en) * 1983-01-27 1984-08-03 Sanofi Sa PYRIDAZINE DERIVATIVE ACIDS ACTIVE ON THE CENTRAL NERVOUS SYSTEM
DE3629929A1 (en) * 1986-09-03 1988-03-10 Thomae Gmbh Dr K NEW SULFONAMIDO-AETHYL COMPOUNDS, MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS AND METHOD FOR THE PRODUCTION THEREOF
FR2642648B1 (en) * 1989-02-07 1991-06-21 Sanofi Sa USE OF ALKYL-5 PYRIDAZINE DERIVATIVES AS ACTIVE MEDICAMENTS ON THE CHOLINERGIC SYSTEM
PT93060B (en) * 1989-02-07 1995-12-29 Sanofi Sa METHOD FOR OBTAINING PYRIDAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
IL96384A (en) 1995-10-31
FR2663326B2 (en) 1992-10-16
NO178967B (en) 1996-04-01
IL96384A0 (en) 1991-08-16
LV11972B (en) 1998-04-20
DK0429344T3 (en) 1997-03-03
EP0429344B1 (en) 1996-09-18
IE75697B1 (en) 1997-09-10
ATE143010T1 (en) 1996-10-15
AU6667290A (en) 1991-05-23
NZ236107A (en) 1992-10-28
AU639043B2 (en) 1993-07-15
KR0164599B1 (en) 1999-01-15
DE69028602D1 (en) 1996-10-24
CA2030133A1 (en) 1991-05-18
LV11972A (en) 1998-02-20
FI101881B1 (en) 1998-09-15
ES2094146T3 (en) 1997-01-16
PT95902B (en) 1998-01-30
NO904984D0 (en) 1990-11-16
PT95902A (en) 1991-09-13
FR2663326A2 (en) 1991-12-20
GR3021933T3 (en) 1997-03-31
NO904984L (en) 1991-05-21
FI905663A (en) 1991-05-18
EP0429344A1 (en) 1991-05-29
DE69028602T2 (en) 1997-04-03
HU907178D0 (en) 1991-05-28
AR247557A1 (en) 1995-01-31
HU207852B (en) 1993-06-28
HUT56078A (en) 1991-07-29
JPH03170465A (en) 1991-07-24
HU211351A9 (en) 1995-11-28
FI101881B (en) 1998-09-15
NO178967C (en) 1996-07-10
KR910009672A (en) 1991-06-28
CA2030133C (en) 1991-05-18
HK1000597A1 (en) 1998-04-09
IE904145A1 (en) 1991-05-22

Similar Documents

Publication Publication Date Title
FI905513A (en) KOMBINATIONER AV FOERENINGAR ISOLERADE FRAON GURKMEJA-ARTER, VILKA AER ANVAENDBARA SOM ANTI-INFLAMMATORISKA AEMNEN.
FI903427A0 (en) I VATTEN AOTERDISPERGERBARA POLYMERISATPULVER, VILKA AER FRAMSTAELLDA GENOM SPRUTNING AV POLYMERISATVATTENDISPERSIONER, OCH ANVAENDNING AV DESSA SOM TILLSATSMEDEL FOER HYDRAULIKSA BINDEMEDEL.
FI901040A0 (en) FOERFARANDE FOER FOERPACKANDE AV ETT SLANGFORMIGT HOELJE, SOM AER I HOPRYNKAD FORM, I ETT SLANGNAET.
FI893557A (en) POLYESTRAR, SOM INNEHAOLLER EN ETERBRYGGA.
FI903028A0 (en) POLYMERBASERADE BLANDNINGSKOMPOSITIONER, SOM INNEHAOLLER DESTRUKTURERAD STAERKELSE.
FI895225A0 (en) FOERFARANDE FOER BORTTAGNING AV TUNGMETALLER, SAERSKILT KADMIUM, FRAON LOESNINGAR SOM INNEHAOLLER FOSFORSYRA.
FI906139A (en) HALOGENERADE OLEFINER, FOERFARANDE FOER FRAMSTAELLNING AV DESSA OCH ANVAENDNING AV DESSA SOM SKADEDJURSBEKAEMPNINGSMEDEL.
FI902433A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV PULVERISERAD POLYDEXTROS SOM AER HUVUDSAKLIGEN FRI FRAON SYROR, OCH KOMPOSITIONER INNEHAOLLANDE DETSAMMA.
FI900870A0 (en) FOERFARANDE FOER BELAEGGNING AV PAPPER MED KOMPOSITIONER, SOM INNEHAOLLER MIKROKAPSLAR.
FI905663A (en) FOERFARANDE FOER ERHAOLLANDE AV PYRIDAZINDERIVAT, VILKA AER ANVAENDBARA SOM LIGNDER AV ACETYLKOLINAKTIGA RECEPTORER.
FI904550A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV SPAONSKIVA OCH SPAONSKIVA, SOM AER FRAMSTAELLD ENLIGT FOERFARANDET.
FI895678A0 (en) FAESTANORDNING FOER FAESTNING AV SKIVOR, SAERSKILT LJUSREKLAMSKIVOR.
FI891146A (en) MUNDSTYCKE, SOM AER LAETT ATT RENA, FOER DISPERSIONSVATTEN.
FI905020A0 (en) ORALA KOMPOSITIONER, SOM INNEHAOLLER MONOPEROXISYROR.
FI885070A (en) FOTOHAERDBAR ELEKTROSTATISK TRYCKSKIVA, SOM INNEHAOLLER ELEKTRONACCEPTOR ELLER -DONATOR.
FI905702A0 (en) KUMARINDERIVAT, FOERFARANDE FOER FRAMSTAELLNING AV DESSA, ANVAENDNING AV DESSA OCH TIAZOLYLAETTIKSSYRADERIVAT SOM MELLANPRODUKTER.
FI890415A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV SUBSTITUERADE IMIDAZOLINFOERENINGAR, VILKA AER ANVAENDBARA SOM TEXTILBEHANDLINGSMEDEL.
FI914502A (en) FOERFARANDE FOER FRAMSTAELLNING AV GOEDSELGRAN GOEDSELGRANULER SOM AER SVARLOESLIGA I VATTEN.
FI914146A0 (en) FOERFARANDE FOER BEHANDLING AV METALLER SOM AVGJUTIT MEDELST SPRUTNING.
FI905325A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV BENZYLPYRROLIDINDERIVAT VILKA AER AKTIVA SOM DOPAMIN-AGONISTER.
FI884154A0 (en) ELMASKIN, SOM INNEFATTAR SLITSKILAR.
FI902902A0 (en) FOERFARANDE FOER FRAMSTAELLNING AV FLEXIBELT POLYURETANSKUM MEDELST ANVAENDNING AV 1,1,1-TRIKLORETAN SOM SKUMAEMNE.
FI900102A0 (en) 7-ARYL- OCHHETEROARYLETRAR AV DESACETYLFORSKOLIN, FOERFRANDE FOER DERAS FRAMSTAELLNING OCH DERAS ANVAENDING SOM LAEKEMEDEL.
FI906269A0 (en) 2,19-METHYLENOXY- OCH 2,19-METHYLENTIO -TVAERBUNDNA STEROIDER SOM AROMATAS- OCH 19-HYDROXYLASINHIBITORER.
FI906263A (en) FOERFARANDE FOER KRYMPNING AV HOLKAR, SOM AER FAESTA VID EL-NAETS TVINNADE FLERTRAODSLUFTLEDNING.

Legal Events

Date Code Title Description
FG Patent granted

Owner name: SANOFI

MM Patent lapsed

Owner name: SANOFI